Baxter International Inc. (NYSE:BAX – Get Free Report) announced a quarterly dividend on Tuesday, May 6th, RTT News reports. Stockholders of record on Friday, May 30th will be paid a dividend of 0.17 per share by the medical instruments supplier on Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date of this dividend is Friday, May 30th.
Baxter International has decreased its dividend by an average of 1.4% per year over the last three years. Baxter International has a dividend payout ratio of 25.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Baxter International to earn $2.73 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 24.9%.
Baxter International Stock Performance
Baxter International stock opened at $30.88 on Wednesday. The business has a 50 day moving average of $30.65 and a 200-day moving average of $31.56. The company has a market capitalization of $15.85 billion, a P/E ratio of -24.13, a P/E/G ratio of 0.93 and a beta of 0.63. Baxter International has a 1 year low of $26.25 and a 1 year high of $40.49. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.43 and a quick ratio of 1.09.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the company. Argus raised Baxter International from a “hold” rating to a “buy” rating in a research report on Monday, February 24th. The Goldman Sachs Group began coverage on Baxter International in a research report on Wednesday, February 26th. They set a “buy” rating and a $42.00 price objective for the company. Morgan Stanley cut their price objective on Baxter International from $30.00 to $28.00 and set an “underweight” rating on the stock in a research note on Monday, May 5th. Barclays increased their target price on shares of Baxter International from $39.00 to $41.00 and gave the company an “overweight” rating in a research report on Monday, March 10th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Baxter International from $38.00 to $36.00 and set a “neutral” rating on the stock in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, Baxter International currently has an average rating of “Hold” and a consensus target price of $37.25.
Check Out Our Latest Report on BAX
Baxter International Company Profile
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Featured Articles
- Five stocks we like better than Baxter International
- Should You Invest in Penny Stocks?
- Waste Management Gets a New Boost—A Tariff Safe Haven?
- How to start investing in penny stocks
- 3 Reasons Wix Could Rally 50% Into the Summer
- The How And Why of Investing in Oil Stocks
- Advance Auto Parts: Did Earnings Defuse Tariff Concerns?
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.